retatrutide approval status 2025 fda Promises Big Weight Loss, but Safety Remains a Question Retatrutide FDA Approval 2025–2026: Phase

A small clinical study suggested that liraglutide reduced monthly migraine days by nearly half in participants with obesity

M.BurgessD

GLP-1s and SGLT2s operate through different mechanisms, and when used together , they can offer synergistic benefits , including: Improved blood sugar control Greater weight loss Lower insulin needs Enhanced cardiovascular and kidney protection Combination therapy may be especially helpful for those with multiple metabolic concerns , but it requires close monitoring and medical guidance

Heres what you need to know Thinking about weight loss injections post-baby

Brands are responsible for ensuring their products are safe, and do not have to prove scientific benefit before selling their products

Among 45 people in this cohort, 29 received the resurfacing treatment while 16 underwent a sham procedure